Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 ...

The integration of wearable technology into healthcare has transformed how individuals monitor their health and manage ...

Wearables have become catalysts for a proactive approach to healthcare, predicting what is about to happen based on current ...

Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

The diabetes community in Leicestershire is among the first in the UK to benefit from a new continuous glucose monitor (CGM), designed to simplify diabetes management.

Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have diabetes.' New survey results and a film released today by Abbott highlight how ...

For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...

The remote patient monitoring (RPM) technology that a patient uses while receiving hospital-at-home care does not follow a ...